Keywords: papillary carcinoma of thyroid, thyroid cancer.
Until recently, papillary carcinoma of the thyroid was regarded as a single group with indolent clinical course and excellent prognosis. This view is now changing. Recent reports1 emphasize that papillary carcinoma should be further subclassified into its variants because of prognostic implications. These variants include follicular,2 tall cell,3 columnar cell,4 diffuse sclerosing, oxyphilic (Hurthle cell), cribriform,5 trabecular,6 muco-epidermoid,7 papillary carcinoma with nodular fasciitis-like stroma,8 and de-differentiated papillary Accordingly, in this report, we have determined the incidence of different types of papillary thyroid neoplasms at Asir Central Hospital, and have correlated this with the clinical findings.
MATERIAL AND METHODS
We searched surgical pathology files that related to goitre specimens received in Asir Central Hospital during a period of 8 years from January 1987 to December 1994. We reviewed only those cases in which a diagnosis of papillary carcinoma was made. The microscopic slides were examined and papillary carcinomas were further subclassified into the following groups based on histological pattern: usual papillary carcinomas; follicular variants of papillary carcinomas; tall cell/columnar variants; diffuse sclerosing variants; oxyphilic variants; and de-differentiated papillary carcinomas. We also reviewed clinical charts to determine such parameters as age, sex and nationality of these patients, aggressiveness of the tumours, types of surgery required and follow-up when available.
- Variants of papillary carcinoma of the thyroid
- Intracystic papillary carcinomas of the breast: a ...
- What’s the connection between dysplasia and neopla...
- Renal Cell Carcinoma (RCC) Kidney Cancer
- placentoid bullous lesion of the lung : Papillary ...
- papillary carcinom another type papillary adenocar...
- Breast Cancer by Papillary Carcinoma
- Thyroid cancer - papillary carcinoma : Medline Plu...
- papillary carcinoma - Thyroid cancer
No comments:
Post a Comment